Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Conditions:   Systemic Lupus Erythematosus;   Rheumatoid Arthritis Interventions:   Drug: PF-06835375;   Drug: Placebo Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials